GSK (GLAXF) Insider Ownership: 0.00 % (As of Jul. 12, 2026)


GLAXF GSK PLC GLAXF
69 GF Score
Price $26.29
GF Value $21.84
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Insider Ownership?

GSK GLAXF 69 Insider Ownership is 0.00 % as of Jul. 12, 2026. GuruFocus rates GLAXF with a GF Score™ of 69/100 and a GF Value™ of $21.84 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GSK's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GSK's Institutional Ownership is 0.07%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GSK's Float Percentage Of Total Shares Outstanding is 99.97%.

GSK Insider Ownership Historical Data

* Premium members only.

The historical data trend for GSK's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Insider Ownership Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GLAXF
69GF Score
GSK PLC GLAXF
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
GSK (GLAXF) has a Insider Ownership of 0.00 % as of Jul. 12, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on GSK and its competitors.
Is GSK's Insider Ownership too high?
GSK's current Insider Ownership is 0.00 %. Overall, GSK has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Insider Ownership compare to LLY and JNJ?
GSK's Insider Ownership of 0.00 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on GSK and its competitors. GSK's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (GLAXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.84, compared to a current price of $26.29 — trading 20.4% above its estimated fair value. The current Insider Ownership is 0.00 %. GSK's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For GSK (GLAXF), the current Insider Ownership is 0.00 % as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (GLAXF) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of $26.29 is trading 20.4% above its estimated GF Value™ of $21.84. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for GLAXF:

  • Insider Ownership: 0.00 %
  • GF Value™: $21.84 vs. price of $26.29 (20.4% above fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the GLAXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
69GF Score

Get the complete analysis for GLAXF

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.29
Price
$21.84
GF Value